Last reviewed · How we verify
APHD-012P
At a glance
| Generic name | APHD-012P |
|---|---|
| Also known as | Placebo |
| Sponsor | Aphaia Pharma US LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects (PHASE1)
- A Study of Distal Jejunal-release Dextrose in Obese Participants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- APHD-012P CI brief — competitive landscape report
- APHD-012P updates RSS · CI watch RSS
- Aphaia Pharma US LLC portfolio CI